key: cord-0300414-n8yytmxt authors: Rowe, Lori A.; Beddingfield, Brandon J.; Goff, Kelly; Killeen, Stephanie Z.; Chirichella, Nicole R.; Melton, Alexandra; Roy, Chad J.; Maness, Nicholas J. title: Intra-host SARS-CoV-2 evolution in the gut of mucosally-infected Chlorocebus aethiops (African green monkeys) date: 2021-08-29 journal: bioRxiv DOI: 10.1101/2021.08.22.457295 sha: e136369dda30cbff5512debb25cd5381906bec68 doc_id: 300414 cord_uid: n8yytmxt In recent months, several SARS-CoV-2 variants have emerged that enhance transmissibility and escape host humoral immunity. Hence, the tracking of viral evolutionary trajectories is clearly of great importance. Little is known about SARS-CoV-2 evolution in nonhuman primate models used to test vaccines and therapies and to model human disease. Viral RNA was sequenced from rectal swabs from Chlorocebus aethiops (African green monkeys) after experimental respiratory SARS-CoV-2 infection. Two distinct patterns of viral evolution were identified that were shared between all collected samples. First, mutations in the furin cleavage site that were initially present in the virus as a consequence of VeroE6 cell culture adaptation were subsequently lost in virus recovered in rectal swabs, confirming the necessity of this motif for viral infection in vivo. Three amino acid changes were also identified; ORF 1a S2103F, and spike D215G and H655Y, that were detected in rectal swabs from all sampled animals. These findings are demonstrative of intra-host SARS-CoV-2 evolution unique to this nonhuman primate species and may identify a host-adapted variant of SARS-CoV-2 that would be useful in future development of primate disease models. The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has killed more than 4 million 31 people to date. Despite the development and rollout of safe and highly effective vaccines on an 32 unparalleled time scale, nearly unchecked viral spread has continued due to vaccine refusal and 33 hesitancy in nations with adequate vaccine supply coupled with inadequate supply in many regions 34 of the world. As a result, several new variants have emerged with enhanced replicative or 35 infectious capacity and immune escape [1] . Since the discovery of the D614G mutation [2, 3] , noted 36 early in the pandemic and found to enable enhanced infection in cells and is now present in all 37 sequenced isolates, several variants of interest and concern (as defined by the CDC) have arisen 38 [1, [4] [5] [6] [7] [8] [9] [10] [11] . These include B.1.1.7 (alpha), which was originally detected in the United Kingdom and 39 rapidly spread globally, B.1.351 (beta), originally detected in South Africa, and P.1 (gamma), 40 originally detected in Japan in a traveler from Brazil. Most recently, the B.1.617.2 (delta) variant 41 has rapidly become globally dominant, which is of great concern due to its greatly enhanced 42 transmissibility relative to other variants and its ability to infect vaccinated individuals [12] . Collectively, these data suggest a concerning scenario wherein there is an ample ontological niche 44 for continued SARS-CoV-2 evolution to facilitate persistence and pandemic spread in populations, including those with preexisting immunity to the virus. Several animal species have been tested in efforts to develop a disease model that faithfully 48 recapitulates human disease and associated pathological consequence, ultimately to be used in Thus, detection of intrahost evolution in these sites may be limited. Importantly, it is now becoming clear that the virus can persist and continue to replicate in gastrointestinal sites [18, 19] , which 58 provides an opportunity to examine viral evolution beyond the first several days of infection and 59 may illuminate tissue-specific compartmentalized evolution. In this study, a focused set of gastrointestinal samples was used to examine viral and host 62 dynamics in SARS-CoV-2 infected African green monkeys (AGM). Consistent patterns of evolution 63 were identified, which is suggestive of species-specific adaptation. The samples were exclusively England Biolabs, Ipswich, MA) as follows: 10l Template RNA, 1l 10M random hexamers, and 73 1l 10mM dNTPs were incubated at 65°C for 5 minutes and then place directly on ice for 1 minute. The following was then added: 4l PSII buffer, 2l 100mM DTT, 1l RNase inhibitor, and 1l PSII 75 reverse transcriptase and incubated at 42°C for 50 minutes, then 70°C for 10 minutes, followed by 76 a hold at 4°C. Primer sequences were trimmed, and sequence reads were aligned to the SARS-CoV-2 genome 84 (WA1/2020 isolate, accession MN985325) using the built-in mapping function in Geneious Prime 85 software. Variants were called that were present at greater than 10% of reads at that site. Variants S2103F mutation in this protein has been detected at low frequency in human samples including in India [25], but is not restricted to a particular clade and through the course of the pandemic has 112 never been detected in greater than 1% of all sequenced isolates (nextstrain.org [26, 27] ). The R682L mutation likely eliminates the furin cleavage site in spike. Reversion to the wild type 115 amino acid, therefore, confirms the necessity of the furin cleavage site for infection in vivo, which 116 has been previously suggested [28] . This finding, although not unexpected but noteworthy, 117 confirms that the loss of the furin cleavage site in vitro can be ascribed to replication in VeroE6 In this study, we define a consistent pattern of viral evolution in SARS-CoV-2-infected AGM. Despite a limited sample size, the ubiquity with which this pattern was detected strongly suggests a 134 selective advantage to the identified mutations. All samples used in this study were derived from 135 rectal rather than respiratory samples, and the data do not clearly suggest a possible mechanism 136 for this selection. It is plausible that replication in the GI tract presents a unique set of selective 137 forces on the virus driving evolution to the mutations identified. Long-term persistence of the virus 138 in the gastrointestinal tract, as has been suggested for SARS-CoV-2 in humans and is a well-described phenomenon in other coronaviruses [33] may also allow selected mutations to 140 accumulate. Even in the latter case, these data suggest the virus continues to replicate and evolve 141 throughout the gastrointestinal system, which may further reveal novel aspects of the virus-host 142 relationship and may have important implications for the detection of variants in wastewater. These data and study support two important conclusions. First, previous reports that an intact furin Alternatively, these mutations could be added to the backbone of variants of concern to assess 152 their impact on experimental infection in AGM or other closely related nonhuman primate species. Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission Disease Severity, and the Vaccine Development Neutralising antibody escape of SARS-CoV-2 spike protein: Risk 199 assessment for antibody-based Covid-19 therapeutics and vaccines SARS-CoV-2 203 variants of concern partially escape humoral but not T-cell responses in COVID-19 204 convalescent donors and vaccinees N-terminal domain antigenic mapping 207 reveals a site of vulnerability for SARS-CoV-2 The emergence and ongoing convergent evolution of 210 the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective 211 landscape Comparison of two highly-effective 214 mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence CoV-2 in the lungs of rhesus macaques, baboons and marmosets SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques Respiratory disease in 226 rhesus macaques inoculated with SARS-CoV-2 Characteristic and quantifiable COVID-19-like 230 abnormalities in CT-and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating 231 macaques (Macaca fascicularis) CoV-2-Infected African Green Monkeys but Not Rhesus Macaques Evolution of antibody immunity to 239 SARS-CoV-2 SARS-CoV-2 infection of African 242 green monkeys results in mild respiratory disease discernible by PET/CT imaging and 243 shedding of infectious virus from both respiratory and gastrointestinal tracts Tracking COVID-19 with wastewater to 247 understand asymptomatic transmission Changing composition of SARS-CoV-2 lineages 250 and rise of Delta variant in England UCSF Chimera--a visualization system for exploratory research and analysis Functional Repertoire of Coronavirus Nonstructural Protein 3 Nsp3 of coronaviruses: Structures and functions of a large 260 multi-domain protein SARS-CoV-2 has observably higher 262 propensity to accept uracil as nucleotide 1 substitution: Prevalence of amino acid 263 substitutions and their predicted functional 2 implications in circulating SARS-CoV-2 in India 264 up to TreeTime: Maximum-likelihood phylodynamic 266 analysis Nextstrain: real-time tracking of pathogen evolution Loss of furin cleavage site attenuates SARS-CoV-2 272 pathogenesis SARS-CoV-2 growth, furin-cleavage-275 site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 276 patients SARS-CoV-2 Alpha, Beta and Delta 279 variants display enhanced Spike-mediated Syncytia Formation 2 3 Transmission of SARS-CoV-2 in domestic 283 cats imposes a narrow bottleneck Title: SARS-CoV-2 variants of 287 concern have acquired mutations associated with an 1 increased spike cleavage 2 3 Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease SARS-CoV-2 neutralizing 294 antibody structures inform therapeutic strategies